| Title |
|
Is Aerosolized Pentamidine for Pneumocystis Pneumonia Prophylaxis in Renal Transplant Recipients Not as Safe as We Might Think? |
|
|
| Publication Date |
|
| Author(s) |
|
| Subject |
|
| Type of document |
|
| DOI |
|
| Abstract |
|
Outbreaks of Pneumocystis pneumonia have been described in renal transplant recipients. Aerosolized pentamidine is frequently used for prophylaxis in this setting. We report our experience of aerosolized pentamidine use in 56 renal transplant recipients and find high rates of adverse reactions in patients with chronic respiratory disease. |
|
|
| Link |
|
| Citation |
|
Antimicrobal Agents and Chemotherapy 2016; 60(4): 2502-2504 |
|
|
| Jornal Title |
|
Antimicrobal Agents and Chemotherapy |
|
|
